Immunotherapy Drugs Market Size to Hit US$ 3.01 Billion By 2030 | Prediction by Growth Plus Reports

News provided by

Jul 29, 2022, 09:00 ET

NEW YORK, July 29, 2022 /PRNewswire/ -- The global immunotherapy drugs market is expected to clock ~US$ 3.01 billion by 2030 owing to the rising prevalence of different types of cancers & infectious diseases coupled with the strong product pipeline.

Download Sample Pages Of this report - https://growthplusreports.com/inquiry/request-sample/immunotherapy-drugs-market/7740

Market Driver

Impending global risk of new infectious and chronic diseases majorly drive the global immunotherapy drugs market. The ongoing pandemic of COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected almost every country worldwide, and resulted in severe outcomes, across all countries.

The first case of COVID-19 was found in December 2019 and by the end of December 2020, the count surged to more than 90.3 million globally. SARS-CoV-2 monoclonal antibodies have shown the potential benefits in animal model for both prevention and treatment of infection.

Therefore, various government bodies, numerous organizations, and the prominent players across the globe are implementing several strategies to fast-track the development of immunotherapy for treatment & prevention of COVID-19. For instance, in May 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients who are at great risk for development to severe Covid-19, comprising hospitalization or death.

The global immunotherapy drugs market has been analyzed from four different perspectives–type, application, end user, and region.

Excerpts from 'By Type Segmentation'

Based on type, the global immunotherapy drugs market has been segmented into:

Monoclonal Antibodies
Vaccines
Interferons & Interleukins
Checkpoint Inhibitors
Others

The monoclonal antibodies segment dominated the market with largest share in 2020. Monoclonal antibodies are laboratory made antibodies that boost the body's natural antibodies or act as antibodies themselves. These antibodies trigger a targeted response by the body to protect it against an attack from a foreign antigen. Monoclonal antibodies are widely used in oncology to recognize tumor cells and to slow or stop their growth. Furthermore, in past few years, monoclonal antibodies have also found application in the treatment of infectious diseases. More recently, monoclonal antibodies are being actively researched and are given emergency use authorizations in order to battle the COVID-19 pandemic. This factor is further expected to increase the growth of the market.

Get a Sample Copy of the prefilled syringes Market Report 2022

Excerpts from 'By Region Segmentation'

Based on region, the global immunotherapy drugs market has been segmented into

North America
Europe
Asia Pacific
Rest of the World

North America dominated the global immunotherapy drugs market in 2021, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to the rising prevalence of different types of cancers and infectious diseases in the region, the presence of prominent players, with the large number of drugs present in the pipeline, favorable reimbursement policies, and the growing funding by public & private organizations for the development of immunotherapies.

Asia Pacific is expected to see significant growth in the immunotherapy drugs market, because of the rising costs of developing healthcare infrastructure. Furthermore, the region's large patient pool and rising cancer cases are expected to drive the growth of the immunotherapy drugs market in the coming years. Advanced immunotherapy drugs have been introduced in China and Japan as these countries are conducting numerous clinical trials and receiving FDA approvals for new drug molecules and combination therapies.

Excerpts from 'Competitive Landscape'

The prominent players operating in the global immunotherapy drugs market are:

Merck & Co., Inc
Novartis AG
Pfizer Inc
Bristol-Myers Squibb Company
Johnson & Johnson Service, Inc
Bayer AG
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
AstraZeneca plc
Amgen Inc
Among others

Immunotherapy Drugs Market Segmentation:

By Type Outlook

Monoclonal Antibodies
Vaccines
Interferons & Interleukins
Checkpoint Inhibitors

By Application Outlook

Cancer
Infectious Diseases
Autoimmune & Inflammatory Diseases

By End User

Hospitals
Specialty Centers

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players

Purchase this Report (Price 5950 USD for a Single-User License) –
https://growthplusreports.com/checkout_token=IAiX8QhvTYJZLEQFoX5mSLyViM8zjkMsS3IkE55w&report_id=7740&license=Single

Check out more healthcare industry related studies published by Growth Plus Reports:

Hydroxychloroquine Market by Disease Indication (Malaria, Systemic Lupus Erythematous, and Rheumatoid Arthritis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores)–Global Outlook & Forecast 2021-2031

Acquired Hemophilia Treatment Market by Type (Hemophilia A, Hemophilia B, and Hemophilia C), by Therapy (Gene Therapy, Immune Tolerance Induction Therapy, Replacement Therapy, and Others), by Treatment (On-Demand and Prophylaxis), and by End-User (Hospitals and Clinics) – Global Outlook & Forecast 2022-2030

Diet Pills Market by Product Type (Over the Counter and Prescription), by Application (Fat Blocking and Appetite Suppression), by Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) - Global Outlook & Forecast 2022-2030

Softgel Capsules Market by Type (Gelatin Capsules, Non-animal Capsules), by Application (Health & Dietary Supplements, Prescribed Medicines), by Manufacturer (Nutraceuticals, Pharmaceuticals, Cosmeceuticals) - Global Outlook & Forecast 2022-2030

Alzheimer's Drugs Market by Drug Type [NMDA Receptor Antagonists and Cholinesterase Inhibitors], Distribution Channel [Hospital Pharmacy, Retail Pharmacy and Online Pharmacy] – Global Outlook & Forecast 2021-2031

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi
Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports